首页> 外文期刊>Acta biomaterialia >Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles
【24h】

Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles

机译:通过Chlitaxel和Homokiol用pH敏感聚合物胶束共递送抑制乳腺癌的多药耐药性和转移

获取原文
获取原文并翻译 | 示例
           

摘要

Graphical abstract Display Omitted Abstract To concurrently suppress multidrug resistance (MDR) and metastasis of breast cancer cells, paclitaxel (PTX) and honokiol (HNK) were coencapsulated into pH-sensitive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly( d , l -lactide) (PEOz-PLA). The physicochemical properties of dual drug-loaded PEOz-PLA micelles were characterized in size, drug loading and in vitro release. The efficiency of MDR reversal for the micelles was testified by synergetic enhancement of cytotoxicity and uptake by MCF-7/ADR cells. The flow cytometry and fluorescence polarization measurement results reinforced the conclusion that down-regulation of P-gp expression and increase of plasma membrane fluidity appeared to be possible mechanisms of MDR reversal by dual drug-loaded PEOz-PLA micelles. Further, the efficient inhibition of tumor metastasis by dual drug-loaded PEOz-PLA micelles was demonstrated by in vitro anti-invasion and anti-migration assessment in MDA-MB-231 cells and in vivo bioluminescence imaging in nude mice. The suppression of MDR and metastasis by the micelles was assigned to synergistic effects of pH-triggered drug release and HNK/PEOz-PLA-aroused P-gp inhibition, and pH-triggered drug release and PTX/HNK-aroused MMPs inhibition, respectively. In conclusion, our findings strengthen the usefulness of co-delivery of PTX and HNK by pH-responsive polymeric micelles for suppression of tumor MDR and metastasis. Statement of Significance Multidrug resistance (MDR) and metastasis are considered to be two of the major barriers for successful chemotherapy. The combination of a chemotherapeutic drug with a modulator has emerged as a promising strategy for efficiently treating MDR cancer and preventing tumor metastasis. Herein, a dual drug (paclitaxel and honokiol)-loaded pH-sensitive polymeric micelle system based on PEOz-PLA was successfully fabricated to ensure that tumor MDR and metastasis could be concurrently suppressed, therefore achieving distinguishing endo/lysosomal pH from physiological pH by accelerating drug release and then enhancing the cytotoxicity of paclitaxel to drug-resistant tumor cells MCF-7/ADR by increasing cellular uptake of paclitaxel, preventing in vitro invasion and migration for MDA-MB-231 cells and in vivo metastasis in nude mice. Further, the mechanism of MDR reversal by dual drug-loaded PEOz-PLA micelles was elucidated to be down-regulation of P-gp expression and increase of plasma membrane fluidity of MCF-7/ADR cells. The present findings strengthen the usefulness of co-delivery of PTX and HNK by pH-responsive polymeric micelles for suppression of tumor MDR and metastasis.
机译:图解摘要显示摘要摘要摘要抑制乳腺癌细胞的多药耐药性(MDR)和转移,紫杉醇(PTX)和HONOKIOL(HNK)基于聚(2-乙基-2-恶唑啉),将PH敏感的聚合物胶束共悬浮成pH敏感的聚合物胶束 - 聚(d,l -lactide)(peoz-pla)。双药物载粒胶束的物理化学性质的特征在于尺寸,药物载荷和体外释放。通过协同增强细胞毒性和通过MCF-7 / ADR细胞的增生,通过协同增强来证明MDR反转的效率。流式细胞术和荧光偏振测量结果增强了该结论:对P-GP表达的下调和血浆膜流动性的增加似乎是MDR反转通过双药物载荷的PEOZ-PLA胶束的机制。此外,通过在MDA-MB-231细胞中的体外抗侵入和抗迁移评估和裸鼠体内生物发光成像,证明了通过双重药物负载的PEOZ-PLA胶束进行高效抑制肿瘤转移的抑制。将MDR和转移的抑制胶束抑制为pH-触发的药物释放和HNK / PEOZ-PLA激增的P-GP抑制的协同作用,分别pH-触发的药物释放和PTX / HNK激增的MMP抑制。总之,我们的研究结果强化了通过pH响应聚合物胶束共同递送PTX和HNK以抑制肿瘤MDR和转移的有用性。显着性多药耐药性(MDR)和转移被认为是成功化疗的两个主要障碍。化学治疗药物与调节剂的组合作为有效治疗MDR癌和预防肿瘤转移的有希望的策略。在此,成功地制造了基于Peoz-PLA的双药(紫杉醇和HOPOKIOL) - 加载的pH敏感的聚合物胶束系统,以确保肿瘤MDR和转移可以同时抑制,因此通过加速来实现与生理pH区别于生理pH的区别药物释放,然后通过增加紫杉醇的细胞摄取,预防MDA-MB-231细胞和裸鼠体内转移的体外侵入和迁移来增强紫杉醇对耐药肿瘤细胞MCF-7 / ADR的耐药肿瘤细胞MCF-7 / ADR的细胞毒性。此外,通过双药物载荷的PEOZ-PLA胶束进行MDR反转的机制被阐明为MCF-7 / ADR细胞的P-GP表达和增加的MCF-7 / ADR细胞的血浆膜流动性的下调。本发现强化了通过pH响应聚合物胶束共同递送PTX和HNK的有用性以抑制肿瘤MDR和转移。

著录项

  • 来源
    《Acta biomaterialia》 |2017年第2017期|共13页
  • 作者单位

    Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems School of;

    Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems School of;

    Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems School of;

    Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems School of;

    Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems School of;

    Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems School of;

    Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems School of;

    Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems School of;

    Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems School of;

    Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems School of;

    Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems School of;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 普通生物学;
  • 关键词

    pH-sensitive polymeric micelles; Multidrug resistance reversal; Tumor metastasis; Honokiol; Paclitaxel; Combined delivery;

    机译:pH敏感的聚合物胶束;多药抗性逆转;肿瘤转移;HONOKIOL;紫杉醇;联合交付;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号